About HeartFlow
HeartFlow is a publicly listed company based in Redwood City (United States) founded in 2007 by John Stevens and Charles Taylor. Cardiovascular diagnostics are provided using CT scans and analytics. HeartFlow has raised $936.05 million across 12 funding rounds from investors including Fidelity Investments, Hayfin and General Electric. The company has 891 employees. HeartFlow was last valued at $2.27 billion in August 2025. Its chief executive, as recorded, is John Farquhar. Its website heartflow.com draws about 48 thousand monthly visits. HeartFlow offers products and services including Roadmap Analysis, FFR CT Analysis, and Plaque Analysis. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is HEARTFLOW, INC. Its competitors include Change Healthcare, AIdoc and Cleerly; 3 of its 3 listed competitors have raised funding.
Company details
HeartFlow was founded in 2007 and is based in Redwood City, United States. Operations focus on the cardiovascular sector, where CT scans and high-performance computing are utilized to analyze blood flow in coronary arteries. Data is supplied to physicians for diagnostic purposes, with studies indicating enhanced accuracy over standard CT scans alone. Services support clinical decision-making in heart disease assessment.
- Headquarters Redwood City, United States
- Employees 891
- Founders John Stevens, Charles Taylor
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website heartflow.com
- Social LinkedIn X Facebook YouTube
- Legal Name Heartflow, Inc.
- Annual Revenue₹1534.13 Cras on Dec 31, 2025
- Net Profit-₹1017.83 Cras on Dec 31, 2025
- EBITDA-₹558.33 Cras on Dec 31, 2025
- Total Equity Funding$936.05M (USD)
in 12 rounds
- Latest Funding Round$98.36M (USD), Series F
Mar 2025
- InvestorsFidelity Investments
& 22 more
- Employee Count891
Products & Services of HeartFlow
HeartFlow offers a comprehensive portfolio of products and services, including Roadmap Analysis, FFR CT Analysis, and Plaque Analysis.
Efficiently detects coronary artery disease from CCTA scans.
Assesses blood flow in coronary arteries for treatment decisions.
Quantifies and characterizes plaque to inform disease risk management.
Apps and channels of HeartFlow
HeartFlow publishes 1 mobile app; its YouTube channel Heartflow has 1.17K subscribers and 24 videos.
Videos from HeartFlow
The most watched videos on HeartFlow's YouTube channel, Heartflow (1.17K subscribers). Click a video to play it here.
More on Heartflow.
Funding Insights of HeartFlow
HeartFlow has successfully raised a total of $936.05M across 12 strategic funding rounds. The most recent funding activity was a Series F round of $98.36 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $936.05M
- Total Rounds 12
- Last Round Series F — $98.36M
- First Round $195,000
(Jul 2009)
- Investors Count 23
Latest 10 of 12 funding rounds of HeartFlow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $98.36M | Series F | – | – | |
| Mar 2023 | $215.86M | Series F | – | Bain Capital Life Sciences | |
| Jun 2019 | $65M | Series E | $1.3B | – | – |
| Feb 2018 | $240M | Series E | $1.5B | Wellington, Baillie Gifford | |
| Nov 2017 | $90M | Series C | $••••• | – | – |
| May 2016 | $99.93M | Series C | – | HealthCor Partners, USVP | – |
| Dec 2011 | $104.7M | Series C | – | – | – |
| Aug 2011 | $338,268 | Grant | – | – | |
| Feb 2011 | $20.42M | Series B | – | – | – |
| Jun 2010 | $10M | Debt – Conventional | – | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2019 | $1.3B | •••••••• |
| Feb 2018 | $1.5B | •••••••• |
| Nov 2017 | $••••• | •••••••• |
Full valuation and stage history of HeartFlow
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $2.27B (Aug 2025). 23 investors in total: 23 institutional.
Investors in HeartFlow
HeartFlow has secured backing from 23 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Hayfin and General Electric.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are targeted for venture capital investments. | 1934 | janushenderson.com | London, United Kingdom | |
Investments are focused on pharmaceutical, biotechnology, and medical sectors. | baincapitallifesciences.com | Boston, United States | ||
Private debt investments are directed across multiple sectors. | 2013 | hayfin.com | London, United Kingdom | |
VC firm that focuses on early stage investments in the US | usvp.com | Menlo Park, United States | ||
| healthcorpartners.com | ||||
Martis Capital is focused on investing in healthcare transformation. | martiscapital.com | Washington, DC, United States | ||
Early-stage US venture capital investments are made by Sandbox Industries. | sandboxindustries.com | Chicago, United States | ||
Private equity investments are directed toward North American companies. | brooksideequity.com | Stamford, United States | ||
Investment firm providing shareholder financing | sectionpartners.com | Palo Alto, United States | ||
Venture capital firm focused on healthcare startups | lifeforcecap.com | San Francisco, United States |
Investor details for HeartFlow
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of HeartFlow
198 people are tracked at HeartFlow (54 in leadership, 9 in board & advisors, 135 in team); the tracked headcount is 891.
| Name | Role | Group |
|---|---|---|
John Farquhar | CEO | Leadership |
John Stevens | Founder | Leadership |
Charles Taylor | Founder | Leadership |
Derek Cooper | VP Of Customer Success | Leadership |
Michael Bieber | Director, Market Development - Structural Heart | Leadership |
Bob Demonte Rn | Area Vice President Of Sales | Leadership |
Bin Zhu | Operations & IT Program Management Director | Leadership |
Francesco Jatta | Vice President Sales & Marketing, EMEA | Leadership |
Vikram Verghese | CFO | Leadership |
Mazi Kiani | Senior Vice President, Quality and Regulatory | Leadership |
Chieng Mirano | Director, Financial Controls and SOX Compliance | Leadership |
Abby (Captain) Doctolero | Director, Clinical Operations | Leadership |
Samuel Jin | Director Sales Operations | Leadership |
Whitney Huey, CCRP | Director, Clinical Operations | Leadership |
Campbell Rogers | EVP, Chief Medical Officer | Leadership |
Sonya Natanzon | VP Of Engineering | Leadership |
Christopher Pauwels | Director, Payer Relations | Leadership |
Rita M. | Executive Assistant To Chief Executive Officer | Leadership |
Nicholas Laudico | VP Of Business Development And Investor Relations | Leadership |
Danny Akina | Area Vice President Of Sales | Leadership |
178 more people are available in the full profile.
Complete people profiles for HeartFlow
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of HeartFlow
HeartFlow is a publicly listed company on the NASDAQ with ticker symbol HTFL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Aug 2025
- Listed onNASDAQ: HTFL
- Listed entityHeartflow, Inc.
- Exchange sectorHealth technology
- ISINUS42238D1072
- Share price$50.32 (-0.47% on the day) · 2026-10-13
- Market capitalisation$4.38B
- EPS (diluted, trailing year)$-1.40
- Volume (last session)1,493,890
Timeline of HeartFlow
5 dated milestones of HeartFlow across 18 years, from founding to its latest funding, stage changes and deals.
- Founded HeartFlow is founded.
- Funding First funding round of $195K.
- Milestone Reaches Unicorn status.
- Funding Latest funding round, Series F, of $98.4M.
- IPO Lists on the stock exchange (IPO).
Competitors of HeartFlow
HeartFlow has 3 listed competitors in our database, 3 of them funded. They include Change Healthcare, AIdoc and Cleerly.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| changehealthcare.com | 2007 | Nashville, United States | $35.99M | 11,310 | Cloud-based solutions are delivered for healthcare payers, providers, and patients. | |
| aidoc.com | 2016 | New York, United States | $424.5M | AI-based single-screen system is provided to streamline medical imaging. | ||
| cleerlyhealth.com | 2016 | Denver, United States | $578.48M | Atherosclerotic plaque is quantified by AI using coronary CT angiograms. |
Detailed competitors of HeartFlow
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of HeartFlow
The website of HeartFlow (heartflow.com) receives about 47.7K visits a month.
- Monthly visits47.7K
▼ 9.4% vs previous month
Websites whose visitors overlap most with HeartFlow. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
healio.com | healio.com | 100% | #72,463 | – | |
| cleerlyhealth.com | 92% | 45.7K | #689,427 | View details | |
cardiovascularbusiness.com | cardiovascularbusiness.com | 87% | #301,603 | – | |
| everlab.com.au | 81% | 133.4K | #261,603 | View details | |
spo.escardio.org | spo.escardio.org | 73% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for HeartFlow
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as HeartFlow (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Heartflow
Complete news archive for HeartFlow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HeartFlow
HeartFlow was founded in 2007 and raised its 1st funding round 2 years after it was founded.
HeartFlow is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
John Farquhar is the CEO of HeartFlow, as recorded in our data.
HeartFlow is a funded company, having raised a total of $936.05M across 12 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $10M, raised on Jul 2009.
HeartFlow has 891 employees.
HeartFlow was founded in 2007 and is based in Redwood City, United States. Operations focus on the cardiovascular sector, where CT scans and high-performance computing are utilized to analyze blood flow in coronary arteries. Data is supplied to physicians for diagnostic purposes, with studies indicating enhanced accuracy over standard CT scans alone. Services support clinical decision-making in heart disease assessment.
HeartFlow's top competitors include Change Healthcare, AIdoc and Cleerly.
HeartFlow offers Roadmap Analysis, FFR CT Analysis, and Plaque Analysis.
Yes, HeartFlow is publicly traded on NASDAQ under the ticker symbol HTFL.
HeartFlow has 23 investors. Key investors include Fidelity Investments, Hayfin, General Electric, HHS, and Baillie Gifford.
The valuation of HeartFlow is $2.27B as of Aug 2025.
HeartFlow operates through Heartflow, Inc..